Table 1: Clinical studies assessing IR in healthy controls, CKD patients, and patients receiving PD, HD, or kidney transplantation (KT).

Patients 𝑛 GDR (mg/kg/min)HOMA index

Controls [38]10 9 . 9 3 ± 1 . 3 3 1.85–1.95
CKD [12]29a 6 . 9 1 ± 2 . 4 6 2 . 2 4 ± 1 . 0 6

Before TxAfter TxBefore KTAfter KT

With PD [37]9a 6 . 3 5 ± 1 . 6 5 8 . 1 8 ± 1 . 7 6
With HD [37]10a 6 . 5 3 ± 1 . 8 4 9 . 7 4 ± 2 . 8 8
1 M after KT [39]34 3 . 0 5 ± 2 . 7 2 1 . 6 7 ± 1 . 2 5
6 M after KT [39]34 3 . 0 5 ± 2 . 7 2 2 . 3 2 ± 2 . 8 3

CKD: chronic kidney disease; GDR: glucose disposal rate; HOMA: homeostasis model assessment for insulin resistance; ESRD: end stage renal disease; CAPD: continuous ambulatory PD; Tx: dialysis treatment; KT: kidney transplantation.
a N ondiabetic.